IV 
119TH CONGRESS 
1ST SESSION 
H. RES. 955 
Recognizing the importance of a continued commitment to ending pediatric 
HIV/AIDS worldwide. 
IN THE HOUSE OF REPRESENTATIVES 
DECEMBER 17, 2025 
Ms. MCCLELLAN (for herself, Ms. KELLY of Illinois, Mr. POCAN, Mr. CARSON, 
Mr. JACKSON of Illinois, Mr. THOMPSON of Mississippi, Ms. NORTON, 
Ms. SEWELL, Mr. WHITESIDES, Ms. VELA´ZQUEZ, Mr. DAVIS of Illinois, 
Ms. WILSON of Florida, Mr. SWALWELL, Ms. GARCIA of Texas, Mrs. RA-
MIREZ, Mrs. WATSON COLEMAN, Mr. TONKO, Mr. CARTER of Louisiana, 
Mr. KRISHNAMOORTHI, Mrs. MCIVER, Ms. ROSS, Ms. RANDALL, Ms. 
TLAIB, and Mr. GARCIA of California) submitted the following resolution; 
which was referred to the Committee on Foreign Affairs, and in addition 
to the Committee on Energy and Commerce, for a period to be subse-
quently determined by the Speaker, in each case for consideration of such 
provisions as fall within the jurisdiction of the committee concerned 
RESOLUTION 
Recognizing the importance of a continued commitment to 
ending pediatric HIV/AIDS worldwide. 
Whereas approximately 53 percent of the 40,800,000 people 
living with the human immunodeficiency virus (HIV), the 
pathogen that causes the acquired immune deficiency 
syndrome (AIDS), worldwide are women and girls, and 
1,400,000 are children in 2024; 
Whereas HIV is a leading cause of death among women of 
childbearing age worldwide; 
VerDate Sep 11 2014 
19:41 Feb 02, 2026
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR955.IH
HR955
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 955 IH 
Whereas AIDS is a leading cause of death among adolescent 
girls globally; 
Whereas women around the world rely on essential prenatal 
and postnatal care to provide screening for diseases such 
as HIV and care for their health and the health of their 
infants; 
Whereas, when antiretroviral drugs are used as prophylaxis, 
mother-to-child transmission of HIV can be reduced to 
less than 5 percent; 
Whereas, in 2005, only 17 percent of pregnant and 
breastfeeding women living with HIV were receiving 
treatment and services for prevention of mother-to-child 
transmission and that number rose to 84 percent in 
2024; 
Whereas 45 percent of new HIV infections globally are 
among women and girls in 2024; 
Whereas, globally, 67 percent of infants born to pregnant 
women living with HIV receive a virologic test within the 
first 2 months of birth; 
Whereas, without treatment, half of all children with HIV 
will die by their second birthday, and 80 percent by their 
fifth birthday; 
Whereas, in 2018, nearly 90 percent of pregnant women liv-
ing with HIV in need of HIV services worldwide live in 
Sub-Saharan Africa; 
Whereas 86 percent of children living with HIV are in Sub- 
Saharan Africa; 
Whereas, despite increased global and United States efforts, 
an estimated 83 percent of the 120,000 children who be-
VerDate Sep 11 2014 
19:41 Feb 02, 2026
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR955.IH
HR955
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 955 IH 
come infected with HIV in 2024 were in Sub-Saharan Af-
rica; 
Whereas progress in meeting the global 95–95–95 treatment 
targets by 2030, which calls for 95 percent of those living 
with HIV to know their status, 95 percent of those who 
know their status to be on treatment, and 95 percent of 
those on treatment to be virally suppressed and sus-
tained, is slower among children (63 percent-87 percent- 
86 percent) than adults (87 percent-89 percent-94 per-
cent); 
Whereas 55 percent of children living with HIV were on life- 
saving antiretroviral therapy in 2024 compared to 78 
percent of adults globally; 
Whereas 75,000 children died of AIDS-related causes in 
2024; 
Whereas, every week, approximately 4,000 adolescent girls 
and young women aged 15 to 24 years became infected 
with HIV globally in 2023, and 3,100 of these infections 
occurred in Sub-Saharan Africa. 
Whereas research efforts at the National Institutes of Health 
have led to extraordinary breakthroughs for children in-
fected with and at risk for contracting HIV; 
Whereas the United States began investing in prevention of 
mother-to-child transmission (PMTCT) services in 2002 
with the announcement of the United States Inter-
national Mother and Child HIV Prevention Initiative; 
Whereas, in 2022, The Global Alliance to End AIDS in Chil-
dren by 2030, which includes international partners like 
the President’s Emergency Plan for AIDS Relief 
(PEPFAR) and the Global Fund to Fight AIDS, Tuber-
culosis and Malaria (Global Fund), was established to ad-
VerDate Sep 11 2014 
19:41 Feb 02, 2026
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR955.IH
HR955
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 955 IH 
dress the growing treatment gap between adults and chil-
dren; 
Whereas the first phase of the Global Alliance focuses on 12 
of the most affected countries, many of whom have 
achieved strong coverage of lifelong antiretroviral therapy 
among pregnant and breastfeeding women since the es-
tablishment of the Alliance; 
Whereas, in January 2024, the United States celebrated the 
21st anniversary of the establishment of PEPFAR; 
Whereas, in fiscal year 2023, PEPFAR supported HIV test-
ing and counseling for more than 71,100,000 people and 
since 
the 
program’s 
inception 
the 
provision 
of 
antiretroviral drug prophylaxis to prevent mother-to-child 
transmission has allowed nearly 5,500,000 babies to be 
born HIV free; 
Whereas, in 2023, the Global Fund supported programs that 
provided 695,000 pregnant women living with HIV with 
antiretroviral drug prophylaxis to prevent the trans-
mission of HIV to their children; 
Whereas, in September 2025, the Department of State in-
cluded the goal of ending mother-to-children transmission 
of HIV in several high-burden countries in its new Global 
Health Strategy; 
Whereas, with the Department of State support for rollout of 
the new long-acting HIV prevention drug lenacapavir, 
women will soon have the option of receiving two injec-
tions over a 1-year period of time to protect themselves 
and their children from acquiring HIV across pregnancy, 
labor and delivery, and breastfeeding; 
Whereas every mother should have the opportunity to fight 
for the life of her child; and 
VerDate Sep 11 2014 
19:41 Feb 02, 2026
Jkt 069200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6300
E:\BILLS\HR955.IH
HR955
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 955 IH 
Whereas every child and adolescent should have access to 
medicines to lead a long and healthy life: Now, therefore, 
be it 
Resolved, That the House of Representatives— 
(1) recognizes that the prevention of mother-to- 
child transmission of HIV is critical to stopping the 
spread of HIV worldwide; 
(2) recognizes that the fight to eliminate pedi-
atric HIV worldwide has been a priority area for the 
United States in its global AIDS response for more 
than over two decades and calls on this leadership 
to continue; 
(3) supports providing adolescents and young 
women with the evidence-based approaches necessary 
to prevent new HIV infections; 
(4) supports providing women and children with 
HIV counseling, testing services, and access to new 
long-acting prevention methods where possible, and 
scaling up access to services and medicines that pre-
vent mother-to-child transmission of HIV and ensure 
pregnant women living with HIV survive and thrive; 
(5) supports scaling up of treatment for HIV 
for children and adolescents including greater access 
to more efficacious antiretroviral drug regimens, 
age-appropriate services, and support for their care-
givers; 
VerDate Sep 11 2014 
19:41 Feb 02, 2026
Jkt 069200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\HR955.IH
HR955
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 955 IH 
(6) supports the 4 pillars of collective action of 
the Global Alliance including; 
(A) closing the treatment gap for pregnant 
and breastfeeding adolescent girls and women 
living with HIV and optimizing continuity of 
treatment; 
(B) preventing and detecting new HIV in-
fections among pregnant and breastfeeding ado-
lescent girls and women; 
(C) accessible testing, optimized treatment, 
and comprehensive care for infants, children, 
and adolescents exposed to and living with HIV; 
and 
(D) addressing rights, gender equality, and 
the social and structural barriers that hinder 
access to services; 
(7) applauds the United States leadership on 
efforts to eliminate new pediatric HIV infections and 
to scale-up pediatric treatment through programs 
and research; 
(8) encourages PEPFAR to continue its leader-
ship through the creation of a standalone pediatric 
HIV strategy that is in alignment with— 
VerDate Sep 11 2014 
19:41 Feb 02, 2026
Jkt 069200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\HR955.IH
HR955
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 955 IH 
(A) the priority actions for children as de-
fined in the standalone pediatric AIDS strat-
egy; and 
(B) the goals of the Global Alliance to End 
AIDS in Children by 2030; and 
(9) reaffirms the United States commitment to 
lead the world to the end of AIDS, to eliminate new 
pediatric HIV infections worldwide, and support 
women, children, adolescents, and families infected 
and affected by HIV. 
Æ 
VerDate Sep 11 2014 
19:41 Feb 02, 2026
Jkt 069200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\HR955.IH
HR955
ssavage on LAPJG3WLY3PROD with BILLS